FYERS
Home
/
Stocks
/
Profit Loss
/
Akums Drugs & Pharmaceuticals Profit & Loss

Akums Drugs & Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
₹1167 Cr₹1158 Cr₹1160 Cr₹1018 Cr₹1024 Cr₹1056 Cr₹1010 Cr₹1033 Cr₹1019 Cr₹944 Cr₹1083 Cr₹1181 Cr₹970 Cr
₹30 Cr₹35 Cr₹34 Cr₹32 Cr₹27 Cr₹18 Cr₹15 Cr₹13 Cr₹7 Cr₹10 Cr₹9 Cr₹7 Cr₹8 Cr
₹1197 Cr₹1193 Cr₹1194 Cr₹1050 Cr₹1051 Cr₹1073 Cr₹1025 Cr₹1047 Cr₹1026 Cr₹954 Cr₹1092 Cr₹1188 Cr₹978 Cr
₹1033 Cr₹1046 Cr₹1052 Cr₹961 Cr₹932 Cr₹1002 Cr₹934 Cr₹947 Cr₹925 Cr₹975 Cr₹1021 Cr₹1060 Cr₹1125 Cr
₹205 Cr₹187 Cr₹181 Cr₹127 Cr₹156 Cr₹111 Cr₹136 Cr₹135 Cr₹135 Cr₹13 Cr₹102 Cr₹159 Cr-₹117 Cr
₹25 Cr₹24 Cr₹24 Cr₹23 Cr₹23 Cr₹5 Cr₹5 Cr₹12 Cr₹13 Cr₹12 Cr₹12 Cr₹14 Cr₹12 Cr
₹139 Cr₹121 Cr₹100 Cr₹66 Cr₹96 Cr₹75 Cr₹91 Cr₹92 Cr₹87 Cr-₹33 Cr₹59 Cr₹87 Cr-₹159 Cr
₹101 Cr₹81 Cr₹68 Cr₹43 Cr₹65 Cr₹150 Cr₹66 Cr₹67 Cr₹61 Cr-₹39 Cr₹195 Cr₹33 Cr-₹187 Cr

Share Price Live Stats

Open (₹)784.40
Volume (₹)1.98 L
High (₹)785.00
Upper Circuit858.60
Low (₹)748.35
Lower Circuit702.50
Prev Close780.55
52W High (₹)796.55
Price761.75
52W Low (₹)409.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)12299.60 Cr
Div. Yield (%)0.38
PE Ratio42.16
Debt to Equity0.02
Price to Book2.15
Book Value216.41
EPS (TTM)18.53
Face Value2.00
ROE (%)8.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
AKUMSNSE
LTP
1W Low
1W High
Market cap (₹)
1905.6-14.4 (-0.75%)
1902
1984.80
4,56,833Cr
9213.5-25.5 (-0.28%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1133.8-57.2 (-4.80%)
1125.10
1187
1,13,217Cr
1391-32.5 (-2.28%)
1376.70
1426.10
1,12,212Cr
1854.2-84.3 (-4.35%)
1811.70
1949
1,01,155Cr
2122.2-49.3 (-2.27%)
2118.10
2192
97,626Cr
2350.1-32.8 (-1.38%)
2341.20
2419.20
96,859Cr
1163.5-14.5 (-1.23%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
761.75-10.85 (-1.40%)
748.35
796.55
12,300Cr

Key Highlights of Akums Drugs & Pharmaceuticals Ltd’s P&L

In 2026-03-31, Akums Drugs & Pharmaceuticals Ltd reported total revenue of ₹4487.74Cr, compared with ₹4174.15Cr in 2025-03-31, reflecting Akums Drugs & Pharmaceuticals Ltd turnover.

Depreciation was ₹154.55Cr and finance costs were ₹94.07Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹382.1Cr in 2026-03-31 as compared to ₹345.25Cr in 2025-03-31.

Net Profit (PAT) was ₹255.19Cr in 2026-03-31 compared with ₹338.18Cr in 2025-03-31.

Earnings per share (EPS) were ₹16.67 in 2026-03-31, compared with ₹22.09 in 2025-03-31.